CNGA3 Gene Achromatopsia Type 2 Genetic Test
Welcome to DNA Labs UAE, where we offer the CNGA3 Gene Achromatopsia Type 2 Genetic Test at a cost of AED 3600.0. This test is designed to diagnose and provide genetic counseling for individuals with achromatopsia type 2, a rare genetic condition that affects color vision and causes vision impairment.
Test Components and Price
- Test Name: CNGA3 Gene Achromatopsia Type 2 Genetic Test
- Price: 3600.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ophthalmology Disorders
- Doctor: Ophthalmologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the CNGA3 Gene Achromatopsia Type 2 Genetic Test, it is important for the patient to provide their clinical history. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the CNGA3 Gene Achromatopsia Type 2 NGS Genetic DNA Test gene CNGA3.
Test Details
The CNGA3 gene is responsible for producing a protein called cyclic nucleotide-gated channel alpha-3. Mutations in this gene can lead to achromatopsia type 2, a condition that impairs color vision and overall visual acuity. The NGS genetic testing method allows us to sequence the entire CNGA3 gene or specific regions of it, enabling us to identify any changes or mutations in the DNA sequence.
By diagnosing achromatopsia type 2 through genetic testing, we can provide accurate information for genetic counseling and help affected individuals and their families better understand the condition. This knowledge can contribute to improved diagnosis, treatment, and management of achromatopsia type 2 and similar genetic conditions.
It is crucial to note that genetic testing should always be performed under the guidance of a healthcare professional. The results should be interpreted in the context of the patient’s medical history and symptoms.
| Test Name | CNGA3 Gene Achromatopsia type 2 Genetic Test |
|---|---|
| Components | |
| Price | 3600.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ophthalmology Disorders |
| Doctor | Ophthalmologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CNGA3 Gene Achromatopsia type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CNGA3 Gene Achromatopsia type 2 NGS Genetic DNA Test gene CNGA3 |
| Test Details |
The CNGA3 gene is associated with a rare genetic condition known as achromatopsia type 2, which affects the ability to see colors and causes vision impairment. This condition is caused by mutations in the CNGA3 gene, which is responsible for producing a protein called cyclic nucleotide-gated channel alpha-3. This protein plays a crucial role in the function of cone cells in the retina, which are responsible for color vision and visual acuity. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the CNGA3 gene that may be responsible for achromatopsia type 2. This test involves sequencing the entire gene or specific regions of the gene to identify any changes or mutations in the DNA sequence. This information can then be used to diagnose the condition and provide genetic counseling to affected individuals and their families. NGS genetic testing is a powerful tool for identifying genetic conditions like achromatopsia type 2 and can help to improve diagnosis, treatment, and management of these conditions. It is important to note that genetic testing should always be performed under the guidance of a healthcare professional and that results should be interpreted in the context of a patient’s medical history and symptoms. |
